ATA42190A - GELATINE CAPSULES CONTAINING RANITIDINE (SALT) - Google Patents

GELATINE CAPSULES CONTAINING RANITIDINE (SALT)

Info

Publication number: ATA42190A
Authority: AT; Austria
Prior art keywords: salt; capsules containing; gelatine capsules; containing ranitidine; ranitidine
Prior art date: 1989-02-23

Application number

AT0042190A

Other languages

German (de)

Other versions

AT401727B (en

Original Assignee

Glaxo Canada

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-02-23

Filing date

1990-02-22

Publication date

1996-04-15

1990-02-22 Application filed by Glaxo Canada filed Critical Glaxo Canada

1996-04-15 Publication of ATA42190A publication Critical patent/ATA42190A/en

1996-11-25 Application granted granted Critical

1996-11-25 Publication of AT401727B publication Critical patent/AT401727B/en

Links

239000001828 Gelatine Substances 0.000 title 1
239000002775 capsule Substances 0.000 title 1
229920000159 gelatin Polymers 0.000 title 1
235000019322 gelatine Nutrition 0.000 title 1
VMXUWOKSQNHOCA-LCYFTJDESA-N ranitidine Chemical compound [O-][N+](=O)/C=C(/NC)NCCSCC1=CC=C(CN(C)C)O1 VMXUWOKSQNHOCA-LCYFTJDESA-N 0.000 title 1
229960000620 ranitidine Drugs 0.000 title 1
150000003839 salts Chemical class 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
- A61K31/341—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide not condensed with another ring, e.g. ranitidine, furosemide, bufetolol, muscarine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicinal Preparation (AREA)

AT0042190A 1989-02-23 1990-02-22 GELATINE CAPSULES CONTAINING RANITIDINE (SALT) AT401727B (en)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB898904182A GB8904182D0 (en)	1989-02-23	1989-02-23	Pharmaceutical compositions

Publications (2)

Publication Number	Publication Date
ATA42190A true ATA42190A (en)	1996-04-15
AT401727B AT401727B (en)	1996-11-25

Family

ID=10652220

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT0042190A AT401727B (en)	1989-02-23	1990-02-22	GELATINE CAPSULES CONTAINING RANITIDINE (SALT)

Country Status (26)

Country	Link
US (1)	US5028432A (en)
JP (1)	JP2856817B2 (en)
KR (1)	KR940006271B1 (en)
AT (1)	AT401727B (en)
AU (1)	AU629303B2 (en)
BE (1)	BE1003123A3 (en)
CA (1)	CA2010692C (en)
CH (1)	CH680567A5 (en)
CY (1)	CY1734A (en)
DE (1)	DE4005650C2 (en)
DK (1)	DK170209B1 (en)
FR (1)	FR2643263B1 (en)
GB (2)	GB8904182D0 (en)
HK (1)	HK89493A (en)
HU (1)	HU211930A9 (en)
IE (1)	IE63179B1 (en)
IL (1)	IL93490A (en)
IT (1)	IT1240768B (en)
LU (1)	LU87681A1 (en)
NL (1)	NL193267C (en)
NZ (1)	NZ232642A (en)
PH (1)	PH26972A (en)
SA (1)	SA90100287B1 (en)
SE (1)	SE512412C2 (en)
ZA (1)	ZA901348B (en)
ZW (1)	ZW1790A1 (en)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1992004893A1 (en) *	1990-09-13	1992-04-02	Smithkline Beecham Corporation	Non-aqueous liquid oral suspensions
US5571533A (en) *	1992-02-07	1996-11-05	Recordati, S.A., Chemical And Pharmaceutical Company	Controlled-release mucoadhesive pharmaceutical composition for the oral administration of furosemide
AU669952B2 (en) *	1992-10-16	1996-06-27	Glaxo Group Limited	Taste-masking compositions of ranitidine
US5433951A (en) *	1993-10-13	1995-07-18	Bristol-Myers Squibb Company	Sustained release formulation containing captopril and method
DE4341310A1 (en) *	1993-12-03	1995-06-08	Hexal Pharma Gmbh	Tablet or capsule containing stable ranitidine hydrochloride Form 1
GB9325445D0 (en)	1993-12-13	1994-02-16	Cortecs Ltd	Pharmaceutical formulations
US5407687A (en) *	1994-02-22	1995-04-18	Glaxo Inc.	Ranitidine solid dosage form
GB9405304D0 (en) *	1994-03-16	1994-04-27	Scherer Ltd R P	Delivery systems for hydrophobic drugs
US5538737A (en) *	1994-11-30	1996-07-23	Applied Analytical Industries, Inc.	Oral compositions of H2 -antagonists
GB9705813D0 (en) *	1997-03-20	1997-05-07	Smithkline Beecham Plc	Novel compositions
AR013261A1 (en) *	1997-08-01	2000-12-13	Smithkline Beecham Corp	PHARMACEUTICAL FORMULATIONS FOR CAMPTOTECINE ANALOGS IN A GELATIN CAPSULE
ATE374602T1 (en) *	2001-12-21	2007-10-15	Supernus Pharmaceuticals Inc	ORAL CAPSULE FORMULATION WITH IMPROVED PHYSICAL STABILITY
JP2006518380A (en) *	2003-01-31	2006-08-10	スミスクライン・ビーチャム・コーポレイション	Solid dispersion composition
KR101152470B1 (en)	2003-08-13	2012-06-01	바이오콘 리미티드	- micro-particle fatty acid salt solid dosage formulations for therapeutic agents
MX2012013955A (en)	2010-06-23	2013-01-24	Colgate Palmolive Co	Therapeutic oral composition.
US9161891B2 (en)	2010-12-20	2015-10-20	Colgate-Palmolive Company	Gelatin encapsulated oral care composition containing dental occlusion actives, hydrophobic viscosity modifier and oil carrier
CN107088168A (en)	2010-12-20	2017-08-25	高露洁-棕榄公司	Include the non-aqueous oral care composition of tooth closing activity thing
CN103260466B (en)	2010-12-20	2016-08-17	高露洁-棕榄公司	Containing hydrophilic active, hydrophobic structure agent and the gelatin encapsulated oral care composition of oil carrier
US20200038376A1 (en) *	2016-11-01	2020-02-06	Johnson & Johnson Consumer Inc.	Liquid oral pharmaceutical dosage form comprising an histamine h2-receptor antagonist and an antacid
CN109010303B (en) *	2017-06-09	2021-05-07	苏州科伦药物研究有限公司	Industrial preparation method of ranitidine hydrochloride capsule
KR102108153B1 (en) *	2017-07-05	2020-05-07	(주)동구바이오제약	Pharmaceutical composition containing a retinoid with improved bioavailability and stability
KR102928295B1 (en) *	2018-09-07	2026-02-13	알.피.쉐러 테크놀러지즈 엘엘씨	Stabilization of solid or semi-solid lipid-based formulations through the addition of hardening and low HLB surfactant(s)

Family Cites Families (22)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3374146A (en) *	1966-04-18	1968-03-19	American Cyanamid Co	Sustained release encapsulation
DE2360796B2 (en) *	1973-12-06	1977-06-02	Edelfettwerke Werner Schlüter, 2000 Hamburg; Glyco Iberica S.A., Gava, Barcelona (Spanien) Vti: Hegel, K.Th., Dr.; Dickel, K., Dipl.-Ing.; Pat.-Anwälte, 2000 Hamburg und 8000 München	MEDICINAL PRODUCTS WITH DELAYED RELEASE OF THE ACTIVE SUBSTANCE IN THE INTESTINE
GB1565966A (en) *	1976-08-04	1980-04-23	Allen & Hanburys Ltd	Aminoalkyl furan derivatives
IT1090703B (en) *	1976-12-03	1985-06-26	Scherer Ltd R P	IMPROVEMENT IN USEFUL COMPOSITIONS SUCH AS DRUG VEHICLES
JPS5919524B2 (en) *	1976-12-17	1984-05-07	中外製薬株式会社	Stable 1α-hydroxyvitamin D-containing preparation
GB1572226A (en) *	1977-11-03	1980-07-30	Hoechst Uk Ltd	Pharmaceutical preparations in solid unit dosage form
JPS55136219A (en) *	1979-04-11	1980-10-23	Sumitomo Chem Co Ltd	Diazepam oily drug
EP0040489A1 (en) *	1980-05-17	1981-11-25	FISONS plc	Mixtures, salts, packages and pharmaceutical compositions containing 5-(2-hydroxypropoxy)-4-oxo-8-propyl-4H-1-benzopyran-2-carboxylic acid or a derivative thereof and an H2 receptor antagonist antihistamine
GB2084580B (en) *	1980-10-01	1984-07-04	Glaxo Group Ltd	Aminoalkyl furan derivative
IL63968A (en) *	1980-10-01	1985-10-31	Glaxo Group Ltd	Form 2 ranitidine hydrochloride,its preparation and pharmaceutical compositions containing it
DE3264782D1 (en) *	1981-10-16	1985-08-22	Sanol Arznei Schwarz Gmbh	Medicinal formulation
JPS58174308A (en) *	1982-04-06	1983-10-13	Fujimoto Seiyaku Kk	Rectal capsule suppository
CA1211374A (en) *	1982-05-14	1986-09-16	Eszter Cholnoky	Pharmaceutical compositions containing more active ingredients
DE3237814A1 (en) *	1982-10-12	1984-04-12	Warner-Lambert Co., 07950 Morris Plains, N.J.	WATER-FREE EMULSIONS AND USE THEREOF
EP0152432B1 (en) *	1983-08-01	1989-03-01	R.P. Scherer Corporation	Sustained release method and product
GB8903804D0 (en) *	1989-02-20	1989-04-05	Sandoz Ltd	Improvements in or relating to organic compounds
GB8426738D0 (en) *	1984-10-23	1984-11-28	Scras	Pyridine derivatives
GB8516083D0 (en) *	1985-06-25	1985-07-31	Glaxo Group Ltd	Heterocyclic compounds
JPH07549B2 (en) *	1986-07-03	1995-01-11	ゼリア新薬工業株式会社	Composition for filling soft capsules
DE3629386A1 (en) *	1986-08-29	1988-03-03	Scherer Gmbh R P	GELATINE CAPSULES AND METHOD FOR THEIR PRODUCTION
IL90245A (en) *	1988-05-11	1994-04-12	Glaxo Group Ltd	Resin adsorbate comprising ranitidine together with a synthetic cation exchange resin, its preparation and pharmaceutical compositions containing it
JPH0482832A (en) *	1988-09-20	1992-03-16	Glaxo Group Ltd	Pharmaceutical composition

1989
- 1989-02-23 GB GB898904182A patent/GB8904182D0/en active Pending
1990
- 1990-02-21 ZW ZW17/90A patent/ZW1790A1/en unknown
- 1990-02-21 LU LU87681A patent/LU87681A1/en unknown
- 1990-02-22 AT AT0042190A patent/AT401727B/en not_active IP Right Cessation
- 1990-02-22 DE DE4005650A patent/DE4005650C2/en not_active Expired - Lifetime
- 1990-02-22 IE IE65190A patent/IE63179B1/en not_active IP Right Cessation
- 1990-02-22 FR FR909002187A patent/FR2643263B1/en not_active Expired - Lifetime
- 1990-02-22 PH PH40086A patent/PH26972A/en unknown
- 1990-02-22 US US07/482,903 patent/US5028432A/en not_active Expired - Lifetime
- 1990-02-22 AU AU50073/90A patent/AU629303B2/en not_active Expired
- 1990-02-22 NL NL9000428A patent/NL193267C/en not_active IP Right Cessation
- 1990-02-22 GB GB9004016A patent/GB2229094B/en not_active Expired - Lifetime
- 1990-02-22 IL IL9349090A patent/IL93490A/en not_active IP Right Cessation
- 1990-02-22 KR KR1019900002250A patent/KR940006271B1/en not_active Expired - Lifetime
- 1990-02-22 ZA ZA901348A patent/ZA901348B/en unknown
- 1990-02-22 JP JP2042288A patent/JP2856817B2/en not_active Expired - Lifetime
- 1990-02-22 IT IT47659A patent/IT1240768B/en active IP Right Grant
- 1990-02-22 CH CH569/90A patent/CH680567A5/fr not_active IP Right Cessation
- 1990-02-22 NZ NZ232642A patent/NZ232642A/en unknown
- 1990-02-22 SE SE9000625A patent/SE512412C2/en unknown
- 1990-02-22 BE BE9000197A patent/BE1003123A3/en not_active IP Right Cessation
- 1990-02-22 DK DK048090A patent/DK170209B1/en not_active IP Right Cessation
- 1990-02-22 CA CA002010692A patent/CA2010692C/en not_active Expired - Lifetime
- 1990-06-23 SA SA90100287A patent/SA90100287B1/en unknown
1993
- 1993-08-26 HK HK894/93A patent/HK89493A/en not_active IP Right Cessation
1994
- 1994-05-06 CY CY173494A patent/CY1734A/en unknown
1995
- 1995-06-29 HU HU95P/P00543P patent/HU211930A9/en unknown

Also Published As

Publication number	Publication date
US5028432A (en)	1991-07-02
BE1003123A3 (en)	1991-12-03
SA90100287B1 (en)	1999-08-15
IL93490A (en)	1994-07-31
CA2010692A1 (en)	1990-08-23
JP2856817B2 (en)	1999-02-10
IT9047659A0 (en)	1990-02-22
IE63179B1 (en)	1995-03-22
HU211930A9 (en)	1996-01-29
FR2643263B1 (en)	1994-09-16
NL9000428A (en)	1990-09-17
ZW1790A1 (en)	1991-10-16
GB9004016D0 (en)	1990-04-18
IE900651L (en)	1990-08-23
HK89493A (en)	1993-09-03
KR940006271B1 (en)	1994-07-14
PH26972A (en)	1992-12-28
DK48090A (en)	1990-08-24
DE4005650A1 (en)	1990-09-06
NZ232642A (en)	1992-07-28
SE9000625D0 (en)	1990-02-22
LU87681A1 (en)	1991-10-08
CA2010692C (en)	1995-12-12
GB2229094A (en)	1990-09-19
DE4005650C2 (en)	1999-03-25
SE512412C2 (en)	2000-03-13
GB8904182D0 (en)	1989-04-05
IT1240768B (en)	1993-12-17
GB2229094B (en)	1993-01-06
IL93490A0 (en)	1990-11-29
NL193267C (en)	1999-05-06
IT9047659A1 (en)	1991-08-22
JPH03200728A (en)	1991-09-02
SE9000625L (en)	1990-08-24
DK170209B1 (en)	1995-06-19
AU629303B2 (en)	1992-10-01
ZA901348B (en)	1991-03-27
CY1734A (en)	1994-05-06
DK48090D0 (en)	1990-02-22
NL193267B (en)	1999-01-04
KR900012612A (en)	1990-09-01
AU5007390A (en)	1990-08-30
CH680567A5 (en)	1992-09-30
FR2643263A1 (en)	1990-08-24
AT401727B (en)	1996-11-25

Legal Events

Date	Code	Title	Description
2010-11-15	ELA	Expired due to lapse of time

Publication	Publication Date	Title
DK68392D0 (en)	1992-05-25	PHARMACEUTICAL PREPARATION CONTAINING CEFUROXIMAXETIL
KR880011653U (en)	1988-08-26	Pharmaceutical capsule
DK237884D0 (en)	1984-05-11	PHARMACEUTICAL PREPARATION
DE69029665D1 (en)	1997-02-20	Cassette containing drug containers
BR8300391A (en)	1983-10-25	MEDICATION BRIDGE
FI883785A0 (en)	1988-08-16	CAPSULE FOER PHARMACEUTICAL VERKSAMT INHALERING SEED I ETT CEILINGS.
NL930032I1 (en)	1993-08-02	7-Amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridine-3-carboxylic acids, methods of preparation thereof and these containing medicines
DK225588A (en)	1988-10-28	PHARMACEUTICAL PREPARATION CONTAINING A LITHIUM SALT
FI902180A0 (en)	1990-04-30	CAPSULES ELECTRODES.
FI832197A0 (en)	1983-06-16	PHARMACEUTICAL BLANDING
GB2229094B (en)	1993-01-06	Pharmaceutical capsules containing ranitidine
IT8747991A0 (en)	1987-05-27	PROCEDURE FOR SEALING HARD GELATIN CAPSULES
FI881745L (en)	1988-10-18	Method for preparing highly stable elastic gelatin capsules for therapeutic purposes
DK109887A (en)	1987-09-05	PHARMACEUTICAL PREPARATION CONTAINING ANTIBODIES
PT88447A (en)	1989-07-31	IMPROVED PROCESS FOR PREPARING GELATINE CAPSULES
DK58983D0 (en)	1983-02-11	PHARMACEUTICAL PREPARATION
FR2638640B1 (en)	1993-11-26	PHARMACEUTICAL SOLUTION
FI912690A7 (en)	1991-12-07	Soft gelatin capsule
FI864474L (en)	1988-05-05	SCREW CAPSULE CAPSULES.
DK163638C (en)	1992-09-07	PHARMACEUTICAL PREPARATION CONTAINING ANTIBIOTIC COMPOUND CL-1957A OR A PHARMACEUTICAL SALT THEREOF
FR2618303B1 (en)	1991-01-04	PREPARATION OF GELATIN WITH HIGH BLOOM DEGREE FROM POULTRY BY-PRODUCTS
DE19675047I2 (en)	2003-06-12	Pharmaceutical composition containing 4-amino-1-hydroxybutane-1, 1-biphosphonic acid
FI830617A0 (en)	1983-02-24	1,4-DIHYDROPYRIDINE DERIVATIVES, DERAS FRAMSTAELLNING OCH DESSA INNEHAOLLANDE PHARMACEUTICALS PRODUCT
DK164670C (en)	1992-12-14	PYRROLOOE3,2,1-HIAAINDOL DERIVATIVES, PROCEDURES FOR PREPARING THEREOF, AND MEDICINES CONTAINING SUCH COMPOUNDS
DK180883D0 (en)	1983-04-25	FISH PACKAGING